BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31469009)

  • 1. Xyloglucan, hibiscus and propolis to reduce symptoms and antibiotics use in recurrent UTIs: a prospective study.
    Cai T; Tamanini I; Cocci A; Di Maida F; Caciagli P; Migno S; Mereu L; Tateo S; Malossini G; Palmieri A; Verze P; Mirone V; Bjerklund Johansen TE
    Future Microbiol; 2019 Aug; 14():1013-1021. PubMed ID: 31469009
    [No Abstract]   [Full Text] [Related]  

  • 2. [Containing bacteria naturally].
    Häckel A
    MMW Fortschr Med; 2016 Apr; 158(8):84. PubMed ID: 27116176
    [No Abstract]   [Full Text] [Related]  

  • 3. Hibiscus extract, vegetable proteases and Commiphora myrrha are useful to prevent symptomatic UTI episode in patients affected by recurrent uncomplicated urinary tract infections.
    Cai T; Tiscione D; Cocci A; Puglisi M; Cito G; Malossini G; Palmieri A
    Arch Ital Urol Androl; 2018 Sep; 90(3):203-207. PubMed ID: 30362679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Methionine associated with Hibiscus sabdariffa and Boswellia serrata extracts are not inferior to antibiotic treatment for symptoms relief in patients affected by recurrent uncomplicated urinary tract infections: Focus on antibiotic-sparing approach.
    Cai T; Cocci A; Tiscione D; Puglisi M; Di Maida F; Malossini G; Verze P; Palmieri A; Mirone V; Bjerklund Johansen TE
    Arch Ital Urol Androl; 2018 Jun; 90(2):97-100. PubMed ID: 29974725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults.
    Costache RC; Novac B; Bardan TR; Agapie DN; Edu A
    Urol Int; 2019; 102(4):468-475. PubMed ID: 30889607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xyloglucan, hibiscus and propolis for the prevention of urinary tract infections: results of in vitro studies.
    Fraile B; Alcover J; Royuela M; Rodríguez D; Chaves C; Palacios R; Piqué N
    Future Microbiol; 2017 Jun; 12():721-731. PubMed ID: 28345957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [UTIPRO PLUS CAPSULE, A NEW INNOVATIVE APPROACH FOR THE TREATMENT OF CYSTITIS AND OTHER BACTERIAL URINARY TRACT INFECTIONS].
    Chakalova G
    Akush Ginekol (Sofiia); 2016; 55 Suppl 1 Pt 2():23-5. PubMed ID: 27509665
    [No Abstract]   [Full Text] [Related]  

  • 8. A Multicenter, Randomized, Placebo-Controlled Study Evaluating the Efficacy of a Combination of Propolis and Cranberry (Vaccinium macrocarpon) (DUAB®) in Preventing Low Urinary Tract Infection Recurrence in Women Complaining of Recurrent Cystitis.
    Bruyère F; Azzouzi AR; Lavigne JP; Droupy S; Coloby P; Game X; Karsenty G; Issartel B; Ruffion A; Misrai V; Sotto A; Allaert FA
    Urol Int; 2019; 103(1):41-48. PubMed ID: 31117097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of reticulated gelatin-hibiscus-propolis against intestinal commensal species commonly associated with urinary tract infections.
    Olier M; Sekkal S; Harkat C; Eutamene H; Theodorou V
    Future Microbiol; 2017 May; 12():505-513. PubMed ID: 28326812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel concentrated cranberry liquid blend, UTI-STAT with Proantinox, might help prevent recurrent urinary tract infections in women.
    Efros M; Bromberg W; Cossu L; Nakeleski E; Katz AE
    Urology; 2010 Oct; 76(4):841-5. PubMed ID: 20399486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xyloglucan, Hibiscus and Propolis in the Management of Uncomplicated Lower Urinary Tract Infections: A Systematic Review and Meta-Analysis.
    Cai T; Anceschi U; Tamanini I; Migno S; Rizzo M; Liguori G; Garcia-Larrosa A; Palmieri A; Verze P; Mirone V; Bjerklund Johansen TE
    Antibiotics (Basel); 2021 Dec; 11(1):. PubMed ID: 35052890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of D-Mannose, ElliroseTM and Lactobacillus Plantarum in treatment of urinary tract recurrent infections (rUTIs): A survey of urologists knowledge about its clinical application.
    Milandri R; Bocchialini T; Maltagliati M; Michele C; Simonetti E; Stefania F; Maestroni UV; Rocco BMC; Micali S
    Acta Biomed; 2020 Mar; 91(1):15-20. PubMed ID: 32191649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a Food Supplement Containing L-Methionine on Urinary Tract Infections in Pregnancy: A Prospective, Multicenter Observational Study.
    Passaro M; Mainini G; Ambrosio F; Sgambato R; Balbi G
    J Altern Complement Med; 2017 Jun; 23(6):471-478. PubMed ID: 28414519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a concentrated cranberry extract prevent recurrent urinary tract infections in women? A pilot study.
    Bailey DT; Dalton C; Joseph Daugherty F; Tempesta MS
    Phytomedicine; 2007 Apr; 14(4):237-41. PubMed ID: 17296290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study.
    Esposito E; Campolo M; Casili G; Lanza M; Franco D; Fazio E; Filippone A; Paterniti I; Cuzzocrea S
    Microb Physiol; 2020; 30(1-6):50-60. PubMed ID: 33070135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of Xyloglucan in Association with the Polysaccharide Gelose in an Experimental Model of Gastroenteritis and Urinary Tract Infections.
    Esposito E; Campolo M; Casili G; Lanza M; Franco D; Filippone A; Peritore AF; Cuzzocrea S
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29932149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardised Chinese herbal treatment delivered by GPs compared with individualised treatment administered by practitioners of Chinese herbal medicine for women with recurrent urinary tract infections (RUTI): study protocol for a randomised controlled trial.
    Flower A; Harman K; Lewith G; Moore M; Bishop FL; Stuart B; Lampert N
    Trials; 2016 Jul; 17():358. PubMed ID: 27460108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up.
    Cai T; Mazzoli S; Nesi G; Boddi V; Mondaini N; Bartoletti R
    J Chemother; 2009 Nov; 21(5):535-41. PubMed ID: 19933045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections.
    Lorenzo-Gómez MF; Padilla-Fernández B; García-Cenador MB; Virseda-Rodríguez ÁJ; Martín-García I; Sánchez-Escudero A; Vicente-Arroyo MJ; Mirón-Canelo JA
    Front Cell Infect Microbiol; 2015; 5():50. PubMed ID: 26090341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary tract infections in the elderly: a review of disease characteristics and current treatment options.
    Rodriguez-Mañas L
    Drugs Context; 2020; 9():. PubMed ID: 32699546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.